My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 329

    1.

    Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.

    Meigs JB, O'donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW.

    Diabetes. 2006 Feb;55(2):530-7.PMID: 16443791 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.

    Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH.

    Diabetes Care. 2002 Aug;25(8):1340-5.PMID: 12145232 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

    Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW.

    JAMA. 2000 Jan 12;283(2):221-8.PMID: 10634338 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

    Meigs JB, Hu FB, Rifai N, Manson JE.

    JAMA. 2004 Apr 28;291(16):1978-86.PMID: 15113816 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.

    Wannamethee SG, Sattar N, Rumley A, Whincup PH, Lennon L, Lowe GD.

    Diabetes Care. 2008 May;31(5):995-1000. Epub 2008 Jan 30.PMID: 18235054 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

    Yu Y, Suo L, Yu H, Wang C, Tang H.

    Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

    8.

    Parental transmission of type 2 diabetes: the Framingham Offspring Study.

    Meigs JB, Cupples LA, Wilson PW.

    Diabetes. 2000 Dec;49(12):2201-7.PMID: 11118026 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.

    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

    Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):593-8.PMID: 11950696 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

    Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, Ferrannini E.

    Diabetes. 2006 Apr;55(4):1133-40.PMID: 16567539 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.

    Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.

    Obesity (Silver Spring). 2006 May;14(5):753-8.PMID: 16855181 [PubMed - indexed for MEDLINE]Related articles

    12.

    Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.

    Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M; Bruneck study.

    Diabetes. 2004 Jul;53(7):1782-9.PMID: 15220202 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.

    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.

    Diabet Med. 2005 Aug;22(8):999-1004.PMID: 16026364 [PubMed - indexed for MEDLINE]Related articles

    14.

    Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.

    Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Döring A, Löwel H, Koenig W; MONICA/KORA Study Group.

    Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):398-405. Epub 2005 Dec 1.PMID: 16322530 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.

    Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH.

    Diabetes. 2002 Apr;51(4):1157-65.PMID: 11916939 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.

    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

    Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):3071-8.PMID: 10591689 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

    Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr.

    Arch Intern Med. 2007 May 28;167(10):1068-74.PMID: 17533210 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.

    Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM, Sattar N.

    Atherosclerosis. 2007 Apr;191(2):418-26. Epub 2006 May 19.PMID: 16712853 [PubMed - indexed for MEDLINE]Related articles

    19.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.

    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.

    Eur J Clin Invest. 2006 May;36(5):345-52.PMID: 16634839 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity